STOK - CIK 0001623526
The table below shows Stoke Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $84.22M | $127.98M | $191.44M | $113.56M | $144.90M | $287.31M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $5.94M | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $305.70M |
| $232.76M |
| $215.34M |
| $244.07M |
| $229.22M |
| $293.93M |
| Property, plant & equipment | $3.15M | $3.91M | $5.82M | $6.67M | $4.14M | $2.67M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $418.43M | $271.56M | $228.34M | $256.07M | $238.87M | $297.93M |
| Accounts payable | $4.94M | $2.50M | $1.70M | $766.00K | $2.38M | $1.50M |
| Total current liabilities | $57.88M | $40.06M | $30.82M | $31.39M | $17.14M | $11.43M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $65.98M | $42.53M | $68.78M | $71.22M | $21.09M | $11.85M |
| Retained earnings | -$497.71M | -$490.83M | -$401.85M | -$297.15M | -$196.08M | -$110.28M |
| Total equity | $352.46M | $229.02M | $159.56M | $184.85M | $217.78M | $286.08M |